FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113883.3.464.1003.196.12.1214.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.196.12.1214/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1214
Version20170504
Statusactive
Date2017-05-04T01:00:13-04:00
NameDTaPVaccine
TitleDTaP Vaccine
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for immunizations with diphtheria, tetanus, and pertussis (DTaP) vaccines.),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent a diphtheria, tetanus, and pertussis (DTaP) vaccine.),(Exclusion Criteria: No exclusions.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
cvxCVX codes used in this IG
ValueSet
2.16.840.1.113883.3.464.1003.196.11.1212DTaP Vaccine

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.12.1214",
  "meta": {
    "versionId": "17",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2017-05-04"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1214",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1214"
    }
  ],
  "version": "20170504",
  "name": "DTaPVaccine",
  "title": "DTaP Vaccine",
  "status": "active",
  "experimental": false,
  "date": "2017-05-04T01:00:13-04:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for immunizations with diphtheria, tetanus, and pertussis (DTaP) vaccines.),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent a diphtheria, tetanus, and pertussis (DTaP) vaccine.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1212"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:a6998453-a2a7-4f57-b34b-af4a170447f6",
    "timestamp": "2025-05-23T22:31:55-04:00",
    "total": 8,
    "contains": [
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "106",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "107",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "110",
        "display": "DTaP-hepatitis B and poliovirus vaccine"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "120",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "146",
        "display": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "198",
        "display": "Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "20",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "50",
        "display": "DTaP-Haemophilus influenzae type b conjugate vaccine"
      }
    ]
  }
}